Timed Ablation of Regulatory CD4+ T Cells Can Prevent Murine AIDS Progression

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 4917-4925

  Beilharz, Manfred W ^a   Sammels, Leanne M ^a   Paun, Andrea ^a   Shaw, Kathryn ^a   Van Eeden, Pauline ^a   Watson, Mark W ^b   Ashdown, Martin L ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c ImmunAid Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; VINBLASTINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; MOUSE; MOUSE STRAIN; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REINFECTION; RETROVIRUS; RODENT DISEASE; T LYMPHOCYTE;

EID: 1842424654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.4917     Document Type: Article

References (51)

1. Aziz, D. C., Z. Hanna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature 338:505.
2. Morse, H. C. D., S. K. Chattopadhyay, M. Makino, T. N. Fredrickson, A. W. Hugin, and J. W. Hartley. 1992. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607.
3. Chattopadhyay, S. K., H. C. d. Morse, M. Makino, S. K. Ruscetti, and J. W. Hartley. 1989. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 86:3862.
4. Pozsgay, J. M., M. W. Beilharz, B. D. Wines, A. D. Hess, and P. M. Pitha. 1993. The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus. J. Virol. 67:5989.
5. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J. 5:2398.
6. Mosier, D. E., R. A. Yetter, and H. C. d. Morse. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766.
7. Chattopadhyay, S. K., M. R. Lander, E. Rands, and D. R. Lowy. 1980. Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc. Natl. Acad. Sci. USA 77:5774.
8. Walchner, M., C. Leib-Mosch, G. Messer, H. Germaier, G. Plewig, and P. Kind. 1997. Endogenous retroviral sequences in the pathogenesis of systemic autoimmune disease. Arch. Dermatol. 133:767.
9. Rasmussen, H. B. 1997. Interactions between exogenous and endogenous retroviruses. J. Biomed Sci. 4:1.
10. Rasmussen, H. B., and J. Clausen. 1997. Possible involvement of endogenous retroviruses in the development of autoimmune disorders, especially multiple sclerosis. Acta Neurol. Scand. Suppl. 169:32.
11. Jolicoeur, P. 2001. Pathogenesis of defective retroviruses. Dev. Biol. (Basel) 106:201.
12. Kubo, Y., Y. Nakagawa, K. Kakimi, H. Matsui, K. Higo, L. Wang, H. Kobayashi, T. Hirama, and A. Ishimoto. 1994. Molecular cloning and characterization of a murine AIDS virus-related endogenous transcript expressed in C57BL/6 mice. J. Gen, Virol. 75:881.
13. gag sequence to a MAIDS-inducing sequence by frameshift mutations. J. Virol. 70:6405.
14. Saoudi, A., B. Seddon, V. Heath, D. Fowell, and D. Mason. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149:195.
15. McGuirk, P., and K. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23:450.
16. - subpopulations. J. Immunol. 165:3105.
17. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
18. Yoshida, K., and H. Kikutani. 2000. Genetic and immunological basis of autoimmune diabetes in the NOD mouse. Rev. Immunogenet. 2:140.
19. + T cells. Immunity 1:553.
20. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
21. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
22. + suppressor T cells. Immunol. Rev. 182:58.
23. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212.
24. Suri-Payer, E., A. Z. Amar, R. McHugh, K. Natarajan, D. H. Margulies, and E. M. Shevach. 1999. Post-thymectomy autoinunune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur. J. Immunol. 29:669.
25. + T cells. J. Autoimmun. 16:115.
26. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18.
27. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194:823.
28. Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59:3128.
29. MacDonald, A. J., M. Duffy, M. T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K. H. Mills. 2002. CD4 T helper type I and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185:720.
30. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221.
31. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024.
32. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625.
33. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. Vandenbroucke-Grauls. B. Appelmelk, and Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:7.
34. + regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 98:9226.
35. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor foxp3. Science 299:1057.
36. Powrie, F., and K. J. Maloy. 2003. Immunology: regulating the regulators. Science 299:1030.
37. + T cell-mediated suppression by dendritic cells. Science 299:1033.
38. Bosio, E., C. L. Cluning, and M. W. Beilharz. 2001. Low-dose orally administered type I interferon reduces splenic B cell numbers in mice. J. Interferon Cytokine Res. 21:721.
39. Ogata, N., N. K. Day, R. D. Buell, R. A. Good, and W. G. Bradley. 1993. Detection of the MAIDS virus using the polymerase chain reaction. PCR Methods Applications 2:272.
40. + suppressor T cells in vivo. Nat. Immunol. 3:33.
41. + T cells to cause regression of an advanced lymphoma. Immunology 71:90.
42. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. d. Morse. 1989. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223.
43. + T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur. J. Immunol. 20:2783.
44. Klinman, D. M., and H. C. d. Morse. 1989. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1144.
45. + T cells which transfer murine AIDS (MAIDS). Cell. Immunol. 156:468.
46. Numata, F., Y. Hitoshi, S. Uehara, and K. Takatsu. 1997. The xid mutation plays an important role in delayed development of murine acquired immunodeficiency syndrome. Int. Immunol. 9:139.
47. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:623.
48. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
49. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135.
50. de Leval, L., S. Colombi, S. Debrus, M. A. Demoitie, R. Greimers, P. Linsley, M. Moutschen, and J. Boniver. 1998. CD28-B7 costimulatory blockade by CTLA4Ig delays the development of retrovirus-induced murine AIDS. J. Virol. 72:5285.
51. De Leval, L., S. Debrus, P. Lane, J. Boniver, and M. Moutschen. 1999. Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency syndrome development. Immunology 98:630.